Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
Rémi GalvesAntoine Da CostaRomain PierrardGeoffrey BayardJean Baptiste GuichardKarl IsaazPublished in: Echocardiography (Mount Kisco, N.Y.) (2020)
In HFrEF pts, β-blocker therapy significantly improves LV and RV systolic remodeling. Accordingly, β-blocker therapy could be applied as soon as possible in HFrEF patients with right ventricular dysfunction so as to limit RV remodeling.